← All compounds
peptide28 listings
SS-31
Mitochondrial Targeting Peptide
Mitochondrial-targeting peptide. Cardiolipin-binding research compound.
Mitochondrial researchCardiac research
/ research index
The research base
Research Maturity
★★★★☆
4/5 — Volume of studies
Evidence Strength
★★★★☆
4/5 — Quality of evidence
Multiple Phase 2/3 trials for mitochondrial dysfunction research.
/ mechanism of action
How it works
Binds cardiolipin in mitochondrial membrane. Stabilizes electron transport chain.
/ research dosing
Common research protocols
Range
40 mg/day (Phase 2 dose)
Frequency
Once daily
Route
Subcutaneous
Cycle
4-12 weeks continuous
Research notes
Elamipretide. Phase 2 trials use 40mg/day SC for mitochondrial disease research. Long-term safety profile being evaluated.
References
PMID: 24550377 →NCT02814097
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Designed for standalone use.
Common pairings
/ side effects
What to know
Generally well-tolerated.
/ timeline
Realistic expectations
8-12 weeks
/ recommendation
Where to buy SS-31
🏆Our pick for SS-31
Modern Research Peptides
10mg · USA · Card / Crypto
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Per-batch comprehensive
- ✓Highest verification tier in stock
- ✓4.8★ community rating
Also solid
/ all listings
Full index, price per mg
Supplier
Trust Score
Size
Price
$/mg
Stock
Buy
FOR RESEARCH USE ONLY. SS-31 is intended for laboratory research and not for human consumption.